Cite
HARVARD Citation
Burgstaller, S. et al. (2018). A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Leukemia & lymphoma. 59 (5), pp. 1121-1126. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Burgstaller, S. et al. (2018). A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Leukemia & lymphoma. 59 (5), pp. 1121-1126. [Online].